GL1X · GenesisL1 explorer

MolNFT v1 · #108525 · protein

PVHL:ELOB:ELOC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4- hydroxy-N-(4-(4-methylthiazol-5-YL)BENZYL)PYRROLIDINE-2-carboxamide (ligand 5)

4W9F · Transcription elongation factor B polypeptide 2: “PVHL:ELOB:ELOC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4…”. X-ray diffraction, 1 ligand (3JU), 9 pockets (best druggability 0.72). MolNFT v1 #108525 on GenesisL1: 3D…

PDB
4W9F
Type
protein
Length
1,317 residues
Chains
12
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transcription elongation factor B polypeptide 2; Transcription elongation factor B…
UniProt
Q15370, Q15369, P40337
Ligands
3JU
Pockets
9 · best druggability 0.72

Structure

x-ray diffraction · 11 distinct chains · 29% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATranscription elongation factor B polypeptide 2protein10417% helix, 35% strandQ15370
BTranscription elongation factor B polypeptide 1protein8748% helix, 15% strandQ15369
CVon hippel-lindau disease tumor suppressorprotein14124% helix, 30% strandP40337
DTranscription elongation factor B polypeptide 2protein9915% helix, 34% strandQ15370
ETranscription elongation factor B polypeptide 1protein8745% helix, 15% strandQ15369
FVon hippel-lindau disease tumor suppressorprotein14227% helix, 30% strandP40337
G, JTranscription elongation factor B polypeptide 2protein10315% helix, 39% strandQ15370
HTranscription elongation factor B polypeptide 1protein8748% helix, 15% strandQ15369
IVon hippel-lindau disease tumor suppressorprotein14426% helix, 29% strandP40337
KTranscription elongation factor B polypeptide 1protein8745% helix, 15% strandQ15369
LVon hippel-lindau disease tumor suppressorprotein13320% helix, 32% strandP40337

Ligands and binding sites

  • 3JU · (4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide · ligand · 4 copies · chains C, F, I, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1640.720.9725empty
21500.520.7918empty
31700.480.76233JU
41650.460.7630empty
51660.440.7525empty

Interfaces

14 interfaces between chains.

  • G–H · 1150 Ų buried · 13 hydrogen bonds · protein-protein
  • A–B · 1116 Ų buried · 13 hydrogen bonds · protein-protein
  • J–K · 1113 Ų buried · 13 hydrogen bonds · protein-protein
  • E–F · 1081 Ų buried · 12 hydrogen bonds · protein-protein
  • H–I · 1054 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 11 modified (artifact).

Compared structures

  • 4W9F · pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylth… · the same entry in another collection · chain K against K, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.